Pearl River Capital, LLC Edwards Lifesciences Corp Transaction History

Pearl River Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $363,611 - $462,718	-5,072 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $340,787 - $443,495	5,072 New	5,072 $405,000
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $65,984 - $101,979	-1,259 Closed	0 $0
Q4 2019 Feb 26, 2020	BUY	$71.7 - $82.09 $90,270 - $103,351	1,259 New	1,259 $294,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.